BMY Stock: A Break Above $57.50 Will Set the Wheels in Motion
The pharmaceutical names are back in the limelight, and this time it's for all the right reasons. It is why I am focusing on Bristol-Myers Squibb Co (NYSE:BMY) stock. There are a number of indications on the BMY stock chart that are starting to suggest that the stock is getting ready to stage a price advance.
This is great news because this sector has been under pressure. A shadow was cast on this sector after a few select companies were caught using predatory pricing polices to inflate their bottom lines. These practices made headlines, and as a result, politicians vowed to curb.
Den vollständigen Artikel lesen ...
The pharmaceutical names are back in the limelight, and this time it's for all the right reasons. It is why I am focusing on Bristol-Myers Squibb Co (NYSE:BMY) stock. There are a number of indications on the BMY stock chart that are starting to suggest that the stock is getting ready to stage a price advance.
This is great news because this sector has been under pressure. A shadow was cast on this sector after a few select companies were caught using predatory pricing polices to inflate their bottom lines. These practices made headlines, and as a result, politicians vowed to curb.
Den vollständigen Artikel lesen ...